NIH-funded research Fellowship grant

Understanding how CUX1 affects blood stem cell diversity

Official title: Establishing CUX1 as a determinant of Hematopoietic Stem cell heterogeneity

Funded at University of Chicago · NIH-10903949 · Data updated 2026-11-12

This study is looking at how a protein called CUX1 affects blood stem cells, which are important for making blood, to help us understand how changes in CUX1 might influence blood health and disorders.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2027
Funding year2024
Award (this year)$53,974
NIH project number5F30HL163992-03
Project IDNIH-10903949 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with blood disorders or conditions that affect hematopoietic stem cells.

Less likely to help

Patients with non-hematological conditions or those not affected by blood disorders may not benefit from this research.

What this research studies

This research investigates the role of a specific transcription factor, CUX1, in the diversity of hematopoietic stem cells (HSCs), which are crucial for blood formation. By using a specially designed mouse model, the study aims to uncover how varying levels of CUX1 influence the behavior and characteristics of these stem cells. The researchers will analyze the relationship between CUX1 expression and the ability of HSCs to repopulate blood cells, potentially revealing new insights into blood disorders. This work could lead to a better understanding of how stem cells make decisions that affect blood health.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for blood-related diseases by targeting the mechanisms that govern stem cell behavior.

How similar studies have gone: Previous research has shown that understanding transcription factors can significantly impact our knowledge of stem cell behavior, indicating potential for success in this area.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Martinez, Tanner Clark — University of Chicago
  • Study coordinator: Martinez, Tanner Clark

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.